Related references
Note: Only part of the references are listed.Long-chain non-coding RNA UCA1 inhibits renal tubular epithelial cell apoptosis by targeting microRNA-206 in diabetic nephropathy
Rucui Yu et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2022)
Calcitriol attenuates renal tubular epithelial cells apoptosis via inhibiting p38MAPK signaling in diabetic nephropathy
Yinfeng Guo et al.
ACTA DIABETOLOGICA (2020)
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
Hiddo J. L. Heerspink et al.
LANCET (2019)
Cell Death in the Kidney
Giovanna Priante et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
TAK1 may promote the development of diabetic nephropathy by reducing the stability of SnoN protein
Yuanyuan Wang et al.
LIFE SCIENCES (2019)
Cellular death, reactive oxygen species (ROS) and diabetic complications
Caroline Maria Oliveira Volpe et al.
CELL DEATH & DISEASE (2018)
TAK1 as the mediator in the protective effect of propofol on renal interstitial fibrosis induced by ischemia/reperfusion injury
Huiping Wu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells
Hak Joo Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
ALA/LA ameliorates glucose toxicity on HK-2 cells by attenuating oxidative stress and apoptosis through the ROS/p38/TGF-β1 pathway
Mingxia Jiang et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Diabetes, oxidative stress and therapeutic strategies
Luc Rochette et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Roles of MAPKAPK-2 and HSP27 in the reduction of renal ischemia-reperfusion injury by ischemic postconditioning in rats
Anzhou Xia et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2014)
Mechanism and In Vitro Pharmacology of TAK1 Inhibition by (5Z)-7-Oxozeaenol
Jiaquan Wu et al.
ACS CHEMICAL BIOLOGY (2013)
Increased oxidative stress in obesity: Implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer
Morihiro Matsuda et al.
OBESITY RESEARCH & CLINICAL PRACTICE (2013)
Cell type-specific function of TAK1 in innate immune signaling
Adebusola A. Ajibade et al.
TRENDS IN IMMUNOLOGY (2013)
Targeting of TAK1 in inflammatory disorders and cancer
Hiroaki Sakurai
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney
Frank Y. Ma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Ablation of TAK1 Upregulates Reactive Oxygen Species and Selectively Kills Tumor Cells
Emily Omori et al.
CANCER RESEARCH (2010)
Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal fibrosis in obstructive nephropathy
Masashi Nishida et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells
Dong-Sub Jung et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
TGF-β concentration specifies differential signaling profiles of growth arrest/differentiation land apoptosis in podocytes
DT Wu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-β type I receptor kinase in puromycin-induced nephritis
ET Grygielko et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
p38 mitogen-activated protein kinase activation and cell localization in human glomerulonephritis: Correlation with renal injury
C Stambe et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Transforming growth factor-β1 potentiates renal tubular epithelial cell death by a mechanism independent of smad signaling
CS Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Targeted disruption of the Tab1 gene causes embryonic lethality and defects in cardiovascular and lung morphogenesis
Y Komatsu et al.
MECHANISMS OF DEVELOPMENT (2002)
Antibody to transforming growth factor-β ameliorates tubular apoptosis in unilateral ureteral obstruction
A Miyajima et al.
KIDNEY INTERNATIONAL (2000)